Current use of health status instruments in randomised controlled trials on patients with rheumatoid arthritis

Disease Management and Health Outcomes

Volumn 3, Issue 6, 1998, Pages 271-277

  Fransen, Jaap ^a   Stucki, Gerald ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; CD5 ANTIGEN; CHLOROQUINE; COLLAGEN TYPE 2; CYCLOSPORIN A; DENILEUKIN DIFTITOX; INTERLEUKIN 1 RECEPTOR; MELOXICAM; METHOTREXATE; NAPROXEN; PENICILLAMINE; PIDOTIMOD; TENIDAP;

CLINICAL TRIAL; HEALTH STATUS; HUMAN; MEDICAL ASSESSMENT; MUSCLE TRAINING; OUTCOMES RESEARCH; PATIENT COUNSELING; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; REVIEW; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; TRAINING; TREATMENT OUTCOME;

EID: 0031926597     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199803060-00002     Document Type: Review

References (3)

1. Kirwan JR. A theoretical framework for process, outcome and prognosis in rheumatoid arthritis. J Rheumatol 1992; 19 (3): 333-6
2. Cheah SY, Clark C, Goldberg L, et al. Outcome measures, pooled index and quality of life instruments in rheumatoid arthritis. J Clin Pharm Ther 1996; 21: 297-316
3. Fries JF, Spitz P, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23 (2): 137-45